Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 1999 May;65(5) > Minerva Anestesiologica 1999 May;65(5):239-44

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ANESTESIOLOGICA

A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care


Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,036


eTOC

 

NEW PHARMACOLOGICAL PROPOSALS IN ANESTHESIA  


Minerva Anestesiologica 1999 May;65(5):239-44

language: English

Why, how and when to monitor neuromuscular function

Viby-Mogensen J.

Department of Anaesthesia and Intensive Care, Copenhagen University Hospital, H:S Rigshospitalet - Copenhagen, Denmark


FULL TEXT  


Background. Traditionally, anaesthetists evaluate the effect of neuromuscular blocking agents clinically. We observe the fasciculations following injection of succinylcholine, the movements of the reservoir bag, the spontaneous movements of the patient, headlift etc. However, with the advent of new fast acting neuromuscular blocking agents and the increasing awareness of the problems of postoperative residual neuromuscular block there is an mounting understanding of the importance of a more objective assessment of the neuromuscular function during anaesthesia.
Purpose of lecture. In this lecture I shall give my personal bias on whether or not routine monitoring of neuromuscular function during anaesthesia is essential. Also, I shall try to answer the question “why, how and when should we monitor neuromuscular function during clinical anaesthesia?”

top of page

Publication History

Cite this article as

Corresponding author e-mail